Perosphere Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Perosphere Pharmaceuticals Ownership

Who owns Perosphere Pharmaceuticals?

Perosphere Pharmaceuticals is owned by AMAG Pharmaceuticals. It was acquired on December 13, 2018.

Perosphere Pharmaceuticals Business Overview

Where is Perosphere Pharmaceuticals headquartered?

Perosphere Pharmaceuticals is headquartered in Danbury, Connecticut.

What sector is Perosphere Pharmaceuticals in?

Perosphere Pharmaceuticals is a life science company.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

Perosphere Pharmaceuticals, Inc.

20 Kenosia Avenue,
Danbury, Connecticut 06810
United States,
(203) 885-1111
www.perospherepharma.com

Perosphere Pharmaceuticals, Inc. is a private clinical-stage company focused on developing rescue drugs. Perosphere Pharma's lead investigational drug product candidate, ciraparantag (PER977), is an FDA Fast Track designated, intravenously administered small synthetic water-soluble new molecular entity intended for use as a reversal agent for the orally administered direct Factor Xa inhibitors and low molecular weight heparin.


 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.